| Mrs Jillian Murray-duchesne, RN | |
|
65 Barrett Rd, New London, NH 03257-5805 | |
| (516) 901-1883 | |
| Not Available |
| Full Name | Mrs Jillian Murray-duchesne |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 65 Barrett Rd, New London, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396443966 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | R168558 (Maryland) | Secondary |
| 163W00000X | Registered Nurse | 053301-21 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jillian Murray-duchesne, RN 65 Barrett Rd, New London, NH 03257-5805 Ph: (516) 901-1883 | Mrs Jillian Murray-duchesne, RN 65 Barrett Rd, New London, NH 03257-5805 Ph: (516) 901-1883 |
News Archive
A study conducted by researchers at the London School Of Hygiene and Tropical Medicine, University of Edinburgh, and Leiden University, suggests that only reopening schools to specific age groups would reduce the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) being transmitted between schools and subsequently households.
Thanks to a $1.2 million grant from the Swedish International Development Cooperation Agency (SIDA), a York University-based group of international researchers are pressing ahead with plans to develop a system for monitoring and promoting human rights for people with disabilities around the world.
An analysis of Kaiser Permanente members in Northern California early in the COVID-19 pandemic found racial and ethnic disparities in the likelihood of testing positive for the coronavirus, but no significant disparities in mortality among those who were hospitalized.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Venlafaxine Hydrochloride Extended-release Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base), the generic version of Wyeth's Effexor XR Capsules, which are used in the treatment of major depressive disorder and social anxiety disorder.
› Verified 6 days ago
Abigail J Sullivan, MSN, FNP-C Registered Nurse Medicare: Medicare Enrolled Practice Location: 276 Newport Rd # 107, New London, NH 03257 Phone: 603-526-4144 | |
Michael Simpson, APRN Registered Nurse Medicare: Medicare Enrolled Practice Location: 273 County Rd, New London, NH 03257 Phone: 603-526-2911 | |
Dr. Margaret Shepard, PHD, PMHNP-BC, APRN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 35 Newport Rd, New London, NH 03257 Phone: 603-865-1321 Fax: 603-865-1327 | |
John Lagasse, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 273 County Rd, New London, NH 03257 Phone: 603-526-5210 | |
Nicole Alexandra Moore, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 158 Hemlock Lane, New London, NH 03257 Phone: 860-428-5627 | |
Sharon Milan-snow, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 273 County Rd, New London, NH 03257 Phone: 603-526-2911 |